 |
Antitrust Law Section At a Glance
EXECUTIVE
COMMITTEE
The Executive Committee of the
NYSBA’s Antitrust Section is composed of practitioners from
private law firms, solo practitioners, in-house counsel and
government. The Executive Committee strives to facilitate the
promotion and education of antitrust law to those who have an interest
in antitrust law.
Executive Committee officers consist of
the Chair, Vice-Chair, Secretary and Finance Officer, who are chosen
each year at the Annual Meeting. Executive Committee meetings are
held monthly throughout the year. There are currently seven
subcommittees within the Executive Committee—Nominating,
Membership and Diversity, Finance, Annual Meeting, Programs,
Publications and Awards—that work on various projects throughout
the year.
EXECUTIVE
COMMITTEE OFFICERS
 William H. Rooney, Chair
William H. Rooney is a partner
in the Litigation Department and Chair of the Antitrust Practice Group
of Willkie Farr & Gallagher LLP in New York, where he specializes in
civil and criminal antitrust matters before the federal courts and the
antitrust enforcement agencies.
Mr. Rooney's antitrust experience includes litigations, mergers,
investigations, and counseling in matters under the Sherman Act
(contracts in restraint of trade and monopolization), the Clayton
Act (mergers and acquisitions), and state antitrust and deceptive
trade practice laws. Mr. Rooney appears regularly in
federal court and before the Antitrust Division of the Department of
Justice and the Federal Trade Commission in connection with antitrust
investigations and substantial acquisitions.
Mr. Rooney’s significant litigation matters include: In re
Modafinil Antitrust Litigation; Apotex v. Teva Pharmaceuticals et al; In
re Nifedipine Antitrust Litigation; In re ACR Tube Litigation; In re
Copper Tubing Antitrust Litigation; Private Equity Antitrust Litigation;
In re Insurance Brokerage Antitrust Litigation; In re Interchange Fee
Antitrust Litigation; American Express v. Visa USA et al.; Teva
Pharmaceuticals USA, Inc. v. FDA; Organon Sanofi-Synthelabo LLC v.
Aventis Pharmaceuticals, Inc.; In re Nabumetone Antitrust Litigation; In
re Options Exchanges Antitrust Litigation; Coalition for Level Playing
Field Robinson-Patman litigation; Intervest v. Bloomberg; Toys "R" Us
antitrust litigation; Salomon Brothers antitrust litigation.
Mr. Rooney’s significant transactional matters include: Teva/Barr;
Pharmion/Celgene; TomTom/Tele Atlas; Mattel/Radica; Teva/IVAX;
GameStop/Electronics Boutique; Teva/Sicor; Teva/Novopharm;
CompUSA/Computer City; Mattel/The Pleasant Co.; Loral/Orion;
Loral/Skynet; Loral/Lockheed Martin; Mattel/Tyco; Mattel/Fisher Price
and numerous antitrust acquisition analyses.
Chambers USA
(2005-2010) ranks Mr. Rooney among the leading individuals
practicing Antitrust Law in New York. Mr. Rooney is also
recommended in Cross-border Competition Handbook 2007/08.
 Eric J. Stock, Vice
Chair
Eric Stock is a partner of
Hogan & Hartson LLP. Mr. Stock’s practice consists of
complex commercial litigation and antitrust matters, with a focus on
antitrust litigation, merger investigations, RICO litigation, and
commercial disputes. His experience includes significant matters
in the telecommunications, computer software, transportation, and
pharmaceutical industries.
Mr.
Stock’s litigation experience includes a number of antitrust
actions brought by customers against parties accused of price-fixing or
monopolization. He also regularly represents clients before the
U.S. Department of Justice and the Federal Trade Commission in
connection with merger and non-merger related government investigations.
Mr. Stock also counsels clients on structuring transactions to
avoid antitrust risk, particularly where antitrust issues have arisen in
connection with a client's defense of its intellectual property
rights.
Prior to
joining Hogan & Hartson, Mr. Stock clerked for The Honorable Allen
G. Schwartz, U.S. District Judge in the Southern District of New York,
and was a litigation associate at a New York-based international law
firm. Mr. Stock received a B.A., summa cum laude, from the
University of Pennsylvania in 1995 and a J.D., magna cum laude, from
Harvard Law School in 1998.
In addition
to serving as the Section’s Finance Officer, Mr. Stock serves as
the Vice-chair of the American Bar Association, Antitrust Law Section,
Corporate Counseling Committee. Mr. Stock is also a member of the
New York State Bar Association’s Task Force on Lawyer
Advertising.
 Lisl
J. Dunlop, Financial Officer
Lisl Dunlop is Counsel in the Antitrust Group of
Shearman & Sterling LLP, where she represents clients in a broad
range of industries in antitrust matters before the federal courts and
the antitrust enforcement agencies.
Ms. Dunlop advises and represents clients in civil
merger and non-merger investigations by the Department of Justice and
Federal Trade Commission, appearing before both agencies
regularly. Recent transactions include
Psychiatric Solutions’ acquisition by Universal Health, Dun &
Bradstreet’s acquisition of QED, and Ciba’s acquisition by
BASF. She also coordinates the
multijurisdictional antitrust defense of cross-border
transactions. In addition, Ms. Dunlop
has represented clients in antitrust class actions under Sections 1 and
2 of the Sherman Act and has advised and represented a number of clients
in criminal antitrust enforcement actions in the U.S. and elsewhere.
Ms. Dunlop has practiced as a competition lawyer in a
number of jurisdictions: she commenced her career at Allen Allen &
Hemsley in Sydney, and worked in
the London office of Shearman & Sterling
in 2001-2002. Ms. Dunlop is admitted to
the bars of New York, the District of Columbia, England,
and New South Wales, Australia. She is active in
the Antitrust and International Sections of the American Bar
Association, is a Vice Chair of the Antitrust Section’s Federal
Civil Enforcement Committee, and is a frequent speaker and writer on
current antitrust issues.
Barbara J. Hart, Secretary
Lowey Dannenberg Cohen & Hart, PC
|
